Analyst consensus rating
Altimmune Analyst Rating: Strong Buy
ALT is rated Strong Buy by 9 analysts with a $17.22 target. As of 2026-08-25.
Direct answer
Altimmune's consensus rating is Strong Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $17.22.
Forecast evidence checked August 25, 2026.
Get free Altimmune email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.17
- Average price target
- $17.22
- High price target
- $28.00
- Low price target
- $11.00
- Low target gap
- +247.6%
- Target upside
- +444.1%
- High target gap
- +784.7%
- Target range width
- 537.1%
- Consensus rating
- Strong Buy
- Analysts
- 9
- Evidence date
- August 25, 2026
- Valid through
- September 1, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Altimmune?
Altimmune has a verified Strong Buy consensus. The same dataset has an average price target of $17.22.
How far are Altimmune's low and high targets from the recorded price?
The low target implies +247.6%, while the high target implies +784.7%.
How many analysts are included in Altimmune's consensus?
The verified consensus includes 9 analysts.
How is Altimmune's target upside or downside calculated?
The average target of $17.22 is divided by the recorded price of $3.17, then one is subtracted to produce +444.1%. This does not guarantee a future return.
When was Altimmune's analyst forecast verified?
The data was verified on 2026-08-25. The dataset is valid through 2026-09-01.